AstraZeneca has become the latest major drugmaker to scale back investment in the United Kingdom, pausing a planned £200 million ($271 million) expansion of its Cambridge research site. The move, which would have created up to 1,000 jobs, highlights growing tensions between the pharmaceutical industry and the UK government over…
With US equities hovering near record levels and economics indicators flashing warning signs – Morgan Stanley is urging investors…
Markets ended the week with a mix of corporate developments, economic data, and breaking news shaping investor sentiment. Tesla…
The world’s largest asset manager is set to use President Donald Trump’s state visit to the United Kingdom next…
Oracle’s historic stock surge this week underscored the central role OpenAI continues to play in global technology markets. The…
A day of significant developments is underway across the Asia-Pacific, as a Wall Street giant makes a key strategic…
The International Energy Agency reported on Friday that the projected development of low-emissions hydrogen projects by 2030 has decreased…
Vietnamese authorities have confirmed a cyberattack on the National Credit Information Center (CIC), raising concerns about the safety of…
Alibaba shares rallied on Friday after the Chinese technology giant unveiled a series of initiatives to expand its artificial…